ASAnwer Zohaib Siddiqi

Anwer Zohaib Siddiqi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anwer Zohaib Siddiqi has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Geographic Differences in Healthcare Utilization Outcomes in Ischemic Stroke: A Population-Level Study from Manitoba

    by Angela Buchel, Anwer Zohaib Siddiqi, Esseddeeg Ghrooda, Anurag Trivedi, Ankur Wadhwa, Claudia Candale-Radu, Radhika Kadangot, Babawale Arabambi, Chetan Vekhande, Naveed Akhtar, et al.

    Objectives: This study aims to evaluate differences in healthcare utilization among patients with ischemic stroke in metropolitan versus non-metropolitan Manitoba. Methods: This study is a population-level analysis using the Discharge Abstract Database from Manitoba. The database includes all patients who received care in a Manitoba facility for ischemic stroke between April 2019 and March 2023. Data were collected on patient demographics, comorbidities and geographical location of stroke presentation (metropolitan Winnipeg vs non-metropolitan). Outcomes included length of stay (LOS), treatment, discharge disposition and mortality. Regression analysis was performed to analyze outcomes, adjusting for age, sex and comorbidities. Results: 3704 (71.6%) patients were admitted in Winnipeg, and 1471 (28.4%) patients were admitted in non-metropolitan Manitoba. Patients presenting to Winnipeg were younger (mean age 72.3 vs 74.3 years) and had higher rates of atrial fibrillation, hypertension, diabetes, chronic kidney disease and heart failure. Patients presenting to Winnipeg had a shorter LOS (16.1 days vs 18.4 days, coefficient 0.05, 95% CI −4.54 to −1.27), had higher rates of intravenous thrombolysis (adjOR 5.13, 95% CI 3.85–6.84), were less likely to be discharged home (39.8% vs 57.5%, adjOR 0.47, 95% CI 0.41–0.53) and were more likely to be transferred for inpatient stroke rehabilitation (adjOR 3.46, 95% CI 2.64–4.54). There were no differences in in-hospital mortality. There was a higher incidence of stroke in Winnipeg compared to non-metropolitan Manitoba ( F -statistic 23.84, p = 0.0028). Conclusions: This study illustrates differences in healthcare utilization outcomes between patients living in metropolitan Winnipeg versus non-metropolitan Manitoba presenting with ischemic stroke.


  • Open Access

    Associations between Canadian deprivation indices and acute stroke outcomes post endovascular thrombectomy - A retrospective cohort study

    by Matthew C So, Nishita Singh, Johanna M Ospel, A Zohaib Siddiqi, Nada Dahroug, Santhosh Annayappa, Kamran Zahid, Susan Alcock, Roman Marin, Ankur Wadhwa, et al.

    Background: Socioeconomic status (SES) has long been recognized as an important determinant of ischemic stroke outcomes, with increased stroke severity and mortality found in patients with lower SES. However, the impact of SES on outcomes post-endovascular thrombectomy in Canada remains largely unknown. Methods: This study is a retrospective cohort analysis of patients from 2015–2024 who received endovascular thrombectomy for large vessel occlusion in Manitoba, Canada (study catchment area 650,000 km 2 , population 1.4 million). Patient residence postal codes were matched with neighborhood-level socioeconomic factors using the Canadian Material and Social Deprivation Index and the Canadian Index of Multiple Deprivation (CIMD). Regression analyses adjusting for baseline demographics, geographic variables, presenting National Institutes of Health Stroke Scale (NIHSS), and time to angiography were conducted to analyze the association between socioeconomic factors and a binarized 90-day modified Rankin Scale (mRS). Results: Overall, 793 patients (51% females, median age 74 years) were included. Unadjusted analyses showed a positive association between poor clinical outcomes and increased economic dependency scores in the CIMD index (OR = 1.18 [95%CI 1.03, 1.37]), as well as decreased CIMD ethno-cultural composition scores (OR = 0.84 [0.73–0.98]). Adjusted analysis did not show consistent associations between procedural outcomes or functionally independent outcomes at 90 days. Interpretation: This Canadian provincial stroke registry study showed SES-related discrepancies in stroke outcomes on an unadjusted basis, but no definite discrepancies after adjustment for age, presenting severity, and time to angiography. These findings suggest that SES-related differences in these variables mediate the observed relationship between SES and poor clinical outcomes.

  • Journal Club: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease

    by A. Zohaib Siddiqi, Nishita Singh

    The "Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease" study was a retrospective analysis of administrative data to examine the safety and efficacy of intravenous thrombolysis (IVT) in patients with moyamoya disease (MMD). Here, we examine this study in detail, looking at its strengths and limitations. The authors identified 3,050 patients with MMD of whom 214 (7.0%) had received IVT. The study used propensity score matching (PSM), a technique which aims to reduce confounding by matching treatment and control groups. After PSM, there were 212 patients in the IVT group and 818 patients in the no-IVT group. A higher proportion of patients in the IVT group had a good outcome (return to home with self-care) than the no-IVT group (53.6% [95% CI 42.7%-63.3%] vs 45.1% [95% CI 39.9%-50.3%]). There were no differences in intracranial hemorrhage (ICH) or mortality between groups. The main strength of this study was the large sample size acquired from nationwide data for this uncommon disease. A few limitations include (1) the observational nature of the study with lack of details about the definition of MMD or of ICH, (2) lack of confirmatory imaging evidence of infarct at 24 hours, and (3) limitations inherent to the technique of PSM. In summary, this study was the first large retrospective study to provide evidence that IVT may be safe in patients with MMD. Future studies are needed to determine whether there is benefit of IVT in these patients.


  • Open Access

    Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial

    by A. Zohaib Siddiqi, Katrina Ignacio, Chitapa Kaveeta, Fouzi Bala, Ayoola Ademola, Aleksander Tkach, Brian H. Buck, Luciana Catanese, Gary Hunter, Dar Dowlatshahi, et al.

    Background: About 25% of patients with acute ischemic stroke have lacunar infarct on follow‐up imaging. In this secondary analysis from the AcT (Alteplase Compared With Tenecteplase) trial, we assessed if there is variation in safety or efficacy of intravenous thrombolysis by infarct type in patients with no visible occlusion. We also determined if this effect differed between tenecteplase and alteplase. Methods and Results: This is a secondary analysis from the AcT trial. Lacunar infarct was defined as single, ≤15 mm, and in regions supplied by perforating arterioles on 24‐hour imaging. Outcomes included symptomatic intracerebral hemorrhage at 24 hours, any hemorrhage on imaging, and 90‐day modified Rankin Scale score. Mixed‐effects regression models adjusted for age, sex, stroke severity, thrombolytic type, and onset‐to‐needle time were used. Of 1577 patients, 456/29.9% had no visible occlusion and interpretable follow‐up imaging (magnetic resonance imaging: 41.2%). Of these 93 (20.4%) (magnetic resonance imaging: 62.3%) had lacunar infarct, 171 (37.5%) (magnetic resonance imaging: 67.4%) had nonlacunar infarct, and 192 (42.1%) (magnetic resonance imaging: 7.3%) had no visible infarct. Four patients (2.3%) in the group with nonlacunar infarct and none in the groups with lacunar infarct and no visible infarct developed symptomatic intracerebral hemorrhage. Any intracranial hemorrhage was highest (21; 12.4%) in the group with nonlacunar infarct. There was no significant interaction between thrombolytic type and treatment outcomes. Conclusions: In the AcT trial, safety of intravenous thrombolysis was similar across all infarct types in patients with no visible occlusion but functional outcomes were worst in patients with nonlacunar infarct. Safety and functional outcomes after intravenous thrombolysis were better in the groups with lacunar infarct and no visible infarct as compared with the overall trial population.


  • Open Access

    Understanding physician preferences about combined thrombolysis and thrombectomy in patients with large vessel occlusion: An international cross-sectional survey

    by A.Z. Siddiqi, N. Kashani, Adam A. Dmytriw, D. Yavagal, G. Saposnik, M. Tymianski, C. Adams, M D Hill, Dar Dowlatshahi, Aristeidis H Katsanos, et al.


  • Open Access

    Cytoprotective agents in stroke: Still uncertainty in the next frontier

    by A. Zohaib Siddiqi, Nima Kashani, Adam A. Dmytriw, Dileep R. Yavagal, Gustavo Saposnik, Michael Tymianski, Corey Adams, Michael D. Hill, Dar Dowlatshahi, Aristeidis H Katsanos, et al.


  • Open Access

    Diagnosis and Management of Acute Ischemic Stroke

    by Anwer Zohaib Siddiqi, Angela Young, Ankur Wadhwa


  • Open Access

    The effect of burst suppression on cerebral blood flow and autoregulation: a scoping review of the human and animal literature

    by A. Zohaib Siddiqi, Logan Froese, Alwyn Gomez, Amanjyot Singh Sainbhi, Kevin Stein, Kangyun Park, Nuray Vakitbilir, Frederick A. Zeiler

    Background:Burst suppression (BS) is an electroencephalography (EEG) pattern in which there are isoelectric periods interspersed with bursts of cortical activity. Targeting BS through anaesthetic administration is used as a tool in the neuro-intensive care unit but its relationship with cerebral blood flow (CBF) and cerebral autoregulation (CA) is unclear. We performed a systematic scoping review investigating the effect of BS on CBF and CA in animals and humans.Methods:We searched MEDLINE, BIOSIS, EMBASE, SCOPUS and Cochrane library from inception to August 2022. The data that were collected included study population, methods to induce and measure BS, and the effect on CBF and CA.Results:Overall, there were 66 studies that were included in the final results, 41 of which examined animals, 24 of which examined humans, and 1 of which examined both. In almost all the studies, BS was induced using an anaesthetic. In most of the animal and human studies, BS was associated with a decrease in CBF and cerebral metabolism, even if the mean arterial pressure remained constant. The effect on CA during periods of stress (hypercapnia, hypothermia, etc.) was variable.Discussion:BS is associated with a reduction in cerebral metabolic demand and CBF, which may explain its usefulness in patients with brain injury. More evidence is needed to elucidate the connection between BS and CA.